According to TCGA data from the HPA, MSH6 expression above a defined threshold (cut-off: 9.86 transcripts per million) is associated with reduced five-year survival in GC patients (32% versus 48% in the low-expression group), though this difference is not statistically significant (p = 0.33). The gene discussed is MSH6; the disease is gastric cancer.